使用新型定量PCR标记物在两动物中普遍和有效地检测杆菌感染
Gayathri Sreedharan1, Yashwant Singh Panwar1, Saketh Murthy1
1CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.
Transboundary and emerging diseases
|April 30, 2025
概括
奇特里多米科斯是一种破坏性两动物疾病,由Batrachochytrium dendrobatidis (Bd) 引起,需要改进诊断. 一种新的qPCR分析提供了灵敏和特定的检测,有助于全球两动物保护工作.
科学领域:
- 类学 类学 类学 类学
- 野生动物病理学 野生动物病理学
- 分子诊断学 分子诊断
背景情况:
- 由Batrachochytrium dendrobatidis (Bd) 和B. salamandrivorans (Bsal) 引起的cytridiomycosis是一种严重的野生动物传染病,影响全球两动物的多样性.
- 目前Bd的诊断试验对某些单元型缺乏敏感性,这阻碍了有效的疾病监测和管理.
- 大约40%的两动物物种面临着由于菌菌病的衰退,需要改进的监测工具.
研究的目的:
- 开发一种通用的,敏感的,特定的,可复制的,负担得起的诊断试验,用于对Batrachochytrium dendrobatidis (Bd) 的稳健检测.
- 为了验证新设计的一步式SYBR绿基定量聚合酶连锁反应 (nSYBR qPCR) 试验的有效性.
主要方法:
- 一个针对Bd基因组的5.8SrRNA和ITS2区域的新型原料对的设计和in-silico测试.
- 对比新的nSYBR qPCR试验的灵敏度和特异性与使用两动物皮肤拭片和培养动物的TaqMan-based qPCR试验.
- 使用印度的样本进行验证,此前使用嵌套PCR进行了测试,并应用于各种两类 (Anura,Caudata,Gymnophiona).
主要成果:
- 新设计的初始对证明了特定的Bd基因组段的强大放大.
- 在检测Bd方面,nSYBR qPCR试验的效率与现有的基于TaqMan的qPCR试验相美.
- 在印度两动物中检测到具有不同感染负载的广泛的胆菌病,包括Anura,Caudata和Gymnophiona.
结论:
- 开发的nSYBR qPCR测定是敏感和特定Bd检测的可靠工具.
- 这种试验可以促进在以前诊断能力有限的地区广泛监测皮菌病.
- 改进的诊断将提高对Bd水库的理解,并为有效的两动物保护战略做出贡献.
更多相关视频
07:20Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR
Published on: February 4, 2018
17.9K
07:37Using Terminal Transferase-mediated dUTP Nick End-labelling TUNEL and Caspase 3/7 Assays to Measure Epidermal Cell Death in Frogs with Chytridiomycosis
Published on: May 16, 2018
10.4K
相关概念视频
Methods of Classification and Identification
Bacterial identification relies on a diverse array of techniques to classify and understand microorganisms, each tailored to uncover specific characteristics. Traditional morphological approaches, while still valuable, are limited for closely related or structurally simple organisms. Modern methods integrate biochemical, serological, genetic, and advanced molecular tools to achieve greater accuracy.Morphological and Biochemical TechniquesMorphological characteristics, such as cell shape and...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
